Kennedy Capital Management’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-19,302
Closed -$1.11M 557
2025
Q2
$1.11M Buy
+19,302
New +$1.55M 0.03% 500

Other funds holding AGL

Kennedy Capital Management's AGL Position: Q3 2025 in Review

Kennedy Capital Management sold out of Agilon Health (AGL) in Q3 2025, closing a stake of 19,302 shares — an estimated $1.11M sold.

Kennedy Capital Management first reported a position in AGL in Q2 2025 and held it in 1 quarter. The position peaked at $1.11M in Q2 2025. 190 funds tracked by Wall St. Rank hold AGL as of Q3 2025.

  • Kennedy Capital Management reported no remaining Agilon Health position as of Q3 2025 after selling out during the quarter.
  • Kennedy Capital Management sold 19,302 Agilon Health shares in Q3 2025, an estimated $1.11M.
  • Kennedy Capital Management first reported a position in Agilon Health in Q2 2025 and held it in 1 quarter.
  • Kennedy Capital Management's Agilon Health position peaked at $1.11M in Q2 2025.
  • 190 funds tracked by Wall St. Rank held Agilon Health as of Q3 2025.

Based on Kennedy Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.